Galileo: $220M valuation, IPO Readiness 49, Series A. Galileo builds AI systems for healthcare diagnostics, developing foundation models that can read medical image. Track live on The IPO Stack.
Galileo builds AI systems for healthcare diagnostics, developing foundation models that can read medical images, pathology slides, and clinical notes to assist physicians in making faster, more accurate diagnoses. Valued at 220M USD with 70M raised, Galileo serves major health systems and competes with Google Health and Tempus in the 100B+ AI healthcare diagnostics market.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Galileo IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Galileo has not publicly announced IPO plans. Track TechStackIPO for the latest signals and subscribe to The IPO Stack for weekly updates.
Galileo is valued at $220M as of May 2023. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Accredited investors can access Galileo shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.
Galileo scores 49/100 (Grade: D) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Galileo has raised $90M in total venture capital and private equity funding, with backing from Emergence Capital, Scale Venture Partners, Basis Set Ventures.
Galileo's notable investors include Emergence Capital, Scale Venture Partners, Basis Set Ventures. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
Galileo is a Artificial Intelligence company. Galileo builds AI systems for healthcare diagnostics, developing foundation models that can read medical images, patholo.